Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma

Oral Oncology

Volumn 50, Issue 4, 2014, Pages 311-318

  Geiger, Jessica L ^a   Lazim, Ahmed F ^b   Walsh, Francis J ^a   Foote, Robert L ^a   Moore, Eric J ^a   Okuno, Scott H ^a   Olsen, Kerry D ^a   Kasperbauer, Jan L ^a   Price, Daniel L ^a   Garces, Yolanda I ^a   Ma, Daniel J ^a   Neben Wittich, Michelle A ^a   Molina, Julian R ^a   Garcia, Joaquin J ^a   Price, Katharine A R ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MOSUL   (Iraq)

Author keywords

Adjuvant therapy; Cisplatin; Head and neck cancer; Human papillomavirus (HPV); Oropharynx cancer; Radiotherapy

Indexed keywords

CISPLATIN; PROTEIN VP16;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DRUG MEGADOSE; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; VERY ELDERLY; WART VIRUS;

ADJUVANT THERAPY; CISPLATIN; HEAD AND NECK CANCER; HUMAN PAPILLOMAVIRUS (HPV); OROPHARYNX CANCER; RADIOTHERAPY;

ANTINEOPLASTIC AGENTS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PAPILLOMAVIRIDAE;

EID: 84895455020     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.01.001     Document Type: Article

References (28)

1. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute, Bethesda, MD. < http://www.seer.cancer.gov/csr/1975-2010/ >, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
2. J.S. Cooper, T.F. Pajak, A.A. Forastiere, J. Jacobs, B.H. Campbell, and S.B. Saxman et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
3. J. Bernier, C. Domenge, M. Ozsahin, K. Matuszewska, J.L. Lefebvre, and R.H. Greiner et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952
4. J. Bernier, J.S. Cooper, T.F. Pajak, M. van Glabbeke, J. Bourhis, and A. Forastiere et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501) Head Neck 27 2005 843 850
5. C.L. Zuur, Y.J. Simis, R.S. Verkaik, J.H. Schornagel, A.J. Balm, and W.A. Dreschler et al. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer Radiother Oncol 89 2008 38 43
6. A.M. Traynor, G.M. Richards, G.K. Hartig, D. Khuntia, J.F. Cleary, and P.A. Wiederholt et al. Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience Head Neck 32 2010 599 606
7. H.A. Wolff, T. Overbeck, R.M. Roedel, R.M. Hermann, M.K. Herrmann, and T. Kertesz et al. Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer J Cancer Res Clin Oncol 135 2009 961 967
8. M. Rampino, U. Ricardi, F. Munoz, A. Reali, C. Barone, and A.R. Musu et al. Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial Clin Oncol (R Coll Radiol) 23 2011 134 140
9. T. Gupta, J.P. Agarwal, S. Ghosh-Laskar, P.M. Parikh, A.K. D'Cruz, and K.A. Dinshaw Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience Head Neck Oncol 1 2009 17
10. A. Homma, N. Inamura, N. Oridate, S. Suzuki, H. Hatakeyama, and T. Mizumachi et al. Concomitant weekly cisplatin and radiotherapy for head and neck cancer Jpn J Clin Oncol 41 2011 980 986
11. J.M. Bachaud, E. Cohen-Jonathan, C. Alzieu, J.M. David, E. Serrano, and N. Daly-Schveitzer Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial Int J Radiat Oncol Biol Phys 36 1996 999 1004
12. V. Espeli, E. Zucca, M. Ghielmini, O. Giannini, A. Salatino, and F. Martucci et al. Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer Oral Oncol 48 2012 266 271
13. S.V. Porceddu, B. Campbell, D. Rischin, J. Corry, L. Weih, and M. Guerrieri et al. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 60 2004 365 373
14. E.M. Sturgis, and P.M. Cinciripini Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110 2007 1429 1435
15. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics CA: A Cancer J Clin 61 2011 212 236
16. K.K. Ang, J. Harris, R. Wheeler, R. Weber, D.I. Rosenthal, and P.F. Nguyen-Tan et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
17. F. Wilcoxon Individual comparisons by ranking methods Biometrics 1 1945 80 83
18. K. Pearson On the criterion that a given system of deviations from the probable in the case of correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling Philos Mag 50 1900 157 175
19. R.A. Fisher Statistical methods for research workers 1934 Oliver and Boyd Edinburgh (Originally published in 1925, 14th ed., 1970)
20. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
21. R. Peto, and J. Peto Asymptotically efficient rank invariant procedures (with discussion) J Roy Stat Soc, Series A 135 1972 185 207
22. S.H. Walker, and D.B. Duncan Estimation of the probability of an event as a function of several independent variables Biometrika 54 1967 167 179
23. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1 1983 41 55
24. D.R. Cox Regression models and life-tables (with discussion) J Roy Stat Soc, Series B 34 1972 187 220
25. G.B. Snow, A.A. Annyas, E.A. van Slooten, H. Bartelink, and A.A. Hart Prognostic factors of neck node metastasis Clin Otolaryngol Allied Sci 7 1982 185 192
26. J.T. Johnson, E.N. Myers, C.D. Bedetti, E.L. Barnes, V.L. Schramm Jr., and P.B. Thearle Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma Arch Otolaryngol 111 1985 534 537
27. J.T. Johnson, R.L. Wagner, and E.N. Myers A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck Cancer 77 1996 181 185
28. P. Sinha, J.S. Lewis Jr., J.F. Piccirillo, D. Kallogjeri, and B.H. Haughey Extracapsular spread and adjuvant therapy in human papillomavirus- related, p16-positive oropharyngeal carcinoma Cancer 118 2012 3519 3530